Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients

Increased predisposition of schizophrenia patients (SP) to development of obesity and insulin resistance suggested common signaling pathway between metabolic syndrome (MetS) and schizophrenia. Deficiency of kynurenine-3-monooxygenase (KMO), enzyme catalyzing formation of 3-hydroxykynurenine (3-HK) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Oxenkrug, Gregory, van der Hart, Marieke, Roeser, Julien, Summergrad, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523985/
https://www.ncbi.nlm.nih.gov/pubmed/28748226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523985/
https://www.ncbi.nlm.nih.gov/pubmed/28748226

Ejemplares similares